Anti-human vista antibodies and use thereof

MYPI2025005955A0Undetermined Publication Date: 2017-11-30JANSSEN PHARMACEUTICALS INC +1
0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025005955
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-07-19
Filing Date
2017-04-14
Publication Date
2017-11-30
Patent Text Reader

Abstract

The invention provides antagonistic and agonistic anti-human VISTA antibodies and antibody fragments. These antagonist antibodies and antibody fragments may be used to inhibit or block VISTA's suppressive effects on T cell immunity and thereby promote T cell immunity. These agonist antibodies and antibody fragments may be used to potentiate or enhance or mimic VISTA's suppressive effects on T cell immunity and thereby suppress T cell immunity. These antagonist antibodies and antibody fragments are especially useful in the treatment of cancer and infectious conditions. These agonist antibodies and antibody fragments are especially useful in the treatment of autoimmunity, allergy, inflammatory conditions, GVHD, sepsis and transplant recipients. Screening assays for identifying these agonists are also provided.
Need to check novelty before this filing date? Find Prior Art